Brain Conflux received its International Standard Serial Number (ISSN) 3079-6016 in 2024, marking its official recognition in the global academic publishing landscape for medical informatics and digital health research.
We are committed to advancing responsible research assessment practices. Our approach aligns with the San Francisco Declaration on Research Assessment (DORA) principles, emphasizing the importance of diverse evaluation criteria beyond traditional citation metrics.
As a new journal (established 2024), we focus on building a strong foundation through rigorous peer review, transparent publishing practices, and genuine engagement with the research community.
Brain Conflux tracks and reports transparent metrics across multiple platforms to support evidence-based decision-making by authors, reviewers, and readers:
Our articles are indexed across major academic platforms:
Brain Conflux maintains rigorous quality standards through our single-anonymous peer review process:
If you are considering submitting to Brain Conflux, our transparent metrics demonstrate our commitment to:
For submission guidelines and more information, please visit our author guidelines page or contact our editorial office directly.
For metrics inquiries: metrics@brainconflux.com
For editorial inquiries: editorial@brainconflux.com
For submission inquiries: submissions@brainconflux.com
Brain Conflux - Advancing the Future of Life Sciences Research
ISSN: 3079-6016 | Open Access | Peer Reviewed | International Editorial Board
Online via OJS platform
Single-anonymous, ~4–6 weeks
Open access, DOI assigned
Impact factors & citation analysis
Published under CC BY 4.0. Authors retain copyright. Ethics governed by COPE guidelines. DOIs registered via Crossref. Publication Ethics →